Mifepristone and Misoprostol for Fetal Demise

Completed · Phase 4

Conditions studied: Anembryonic Pregnancy, Gestation Abnormality, Intrauterine Fetal Demise Term

In brief

This is a pilot clinical trial to evaluate whether the medical management of early pregnancy failure with mifepristone and misoprostol is an effective and acceptable treatment. Subjects with early pregnancy failure receive mifepristone followed 24 hours later by vaginal misoprostol for medical management. Subjects then return on study day 3 for a repeat ultrasound to assess passage of pregnancy tissue. subjects who still have a gestational sac present at Day 3 receive a second dose of vaginal misoprostol. All subjects have a follow-up at Day 15, by phone for those who passed the pregnancy with the first dose of misoprostol, and in person for those who received a second dose. Questionnaires are administered at the beginning and end of the study to determine acceptability.

Key facts

Study ID
NCT00177372
Run by
University of Pittsburgh
People needed
30
Starts
2005-01-01
Expected to finish
2005-09-01
Last updated by the study team
2016-01-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.